Basic Information
Lacosamide
53746-924
Regulatory Information
53746-924
ANDA204857
C73584
May 17, 2023
USA
These highlights do not include all the information needed to use LACOSAMIDE TABLETS safely and effectively. See full prescribing information for LACOSAMIDE TABLETS. LACOSAMIDE tablets, for oral use, CV Initial U.S. Approval: 2008
HUMAN PRESCRIPTION DRUG LABEL
1
Company Information
Active Ingredients
SILICON DIOXIDE
Code: ETJ7Z6XBU4
Class Code: IACT
CROSPOVIDONE (12 MPA.S AT 5%)
Code: 40UAA97IT9
Class Code: IACT
FERRIC OXIDE YELLOW
Code: EX438O2MRT
Class Code: IACT
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Code: 2165RE0K14
Class Code: IACT
CELLULOSE, MICROCRYSTALLINE
Code: OP1R32D61U
Class Code: IACT
MAGNESIUM STEARATE
Code: 70097M6I30
Class Code: IACT
POLYETHYLENE GLYCOL, UNSPECIFIED
Code: 3WJQ0SDW1A
Class Code: IACT
TITANIUM DIOXIDE
Code: 15FIX9V2JP
Class Code: IACT
TALC
Code: 7SEV7J4R1U
Class Code: IACT
POLYVINYL ALCOHOL (94000 MW)
Code: C1MS7RRZ6L
Class Code: IACT
Active Moieties
LACOSAMIDE
Code: 563KS2PQY5